海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
219件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
- Alzheimer's Disease
- Australia, Austria, Belgium, Bulgaria, Canada, Costa Rica, Croatia, Czech Republic, Czechia, Denmark, Finland, France, Germany, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Poland, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2016-01-28
Authorised
- A Safety and Efficacy Study for Alzheimer's Disease (Prodromal AD)
- prodromal Alzheimer's Disease MedDRA version: 16.0 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes) System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Finland, France, Germany, Italy, Japan, Netherlands, New Zealand, Norway, South Africa, Spain, Switzerland, United Kingdom, United States
- 2013-09-17
Not recruiting
- A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
- Alzheimer's Disease
- Argentina, Australia, Belgium, Brazil, Canada, China, Denmark, Estonia, France, Germany, Greece, Guatemala, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Norway, Peru, Poland, Portugal, Russian Federation, Serbia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States
- 2017-03-28
Not recruiting
- Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)
- Alzheimer Disease
- Argentina, Australia, Canada, South Africa, United States
- 2005-09-06
Not recruiting
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
- Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus
- Argentina, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Former Serbia and Montenegro, Guatemala, Hungary, India, Israel, Latvia, Lithuania, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Ukraine, United States
- 2006-11-01
Not recruiting
- A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
- Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease
- Argentina, Australia, Canada, Chile, Czech Republic, Czechia, Germany, Italy, Spain, United States
- 2008-06-30
Authorised
- A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
- 2018-09-26
Authorised
- A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
- 2018-08-31
Recruiting
- Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
- Alzheimer Disease
- Australia, Brazil, Canada, China, Colombia, France, Germany, Hungary, Italy, Japan, Lithuania, Peru, Russian Federation, Spain, Taiwan, United States
- 2018-02-19
Not Recruiting
- Efficacy and safety study of benralizumab added to medium dose inhaled corticosteroid plus LABA in patients with uncontrolled asthma
- Asthma MedDRA version: 16.0 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Argentina, Brazil, Bulgaria, Germany, Japan, Mexico, Peru, Poland, Russian Federation, South Africa, Sweden, Turkey, Ukraine, United States
- 2013-09-30
